The Efficacy and Safety of Nab-paclitaxel Plus S-1 in First-line Treatment of Advanced Biliary Tract Adenocarcinoma

NCT03830606 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

54

Enrollment

UNKNOWN

Sponsor class

Conditions

Biliary Tract Cancer

Interventions

DRUG: Nab-paclitaxel,S-1

Sponsor

Aiping Zhou